nach oben

European Journal of Clinical Microbiology & Infectious Diseases

Erschienen in:

01.07.2014 | Review

Bacterial proteases: targets for diagnostics and therapy

verfasst von: W. E. Kaman, J. P. Hays, H. P. Endtz, F. J. Bikker

Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases | Ausgabe 7/2014

Einloggen, um Zugang zu erhalten

Abstract

Proteases are essential for the proliferation and growth of bacteria, and are also known to contribute to bacterial virulence. This makes them interesting candidates as diagnostic and therapeutic targets for infectious diseases. In this review, the authors discuss the most recent developments and potential applications for bacterial proteases in the diagnosis and treatment of bacterial infections. Current and future bacterial protease targets are described and their limitations outlined.

Rawlings ND, Barrett AJ, Bateman A (2012) MEROPS: the database of proteolytic enzymes, their substrates and inhibitors. Nucleic Acids Res 40:D343–D350PubMedCrossRefPubMedCentral

Loesche WJ, Giordano J, Hujoel PP (1990) The utility of the BANA test for monitoring anaerobic infections due to spirochetes (Treponema denticola) in periodontal disease. J Dent Res 69:1696–1702PubMedCrossRef

Drag M, Salvesen GS (2010) Emerging principles in protease-based drug discovery. Nat Rev Drug Discov 9:690–701PubMedCrossRefPubMedCentral

Zindel S, Kaman WE, Fröls S et al (2013) The papain inhibitor (SPI) of Streptomyces mobaraensis inhibits bacterial cysteine proteases and is an antagonist of bacterial growth. Antimicrob Agents Chemother 57:3388–3391PubMedCrossRefPubMedCentral

Humann J, Lenz LL (2009) Bacterial peptidoglycan degrading enzymes and their impact on host muropeptide detection. J Innate Immun 1:88–97PubMedCrossRefPubMedCentral

Margolin W (2009) Sculpting the bacterial cell. Curr Biol 19:R812–R822PubMedCrossRefPubMedCentral

Smith TJ, Blackman SA, Foster SJ (2000) Autolysins of Bacillus subtilis: multiple enzymes with multiple functions. Microbiology 146:249–262PubMed

Yamamoto H, Miyake Y, Hisaoka M, Kurosawa S, Sekiguchi J (2008) The major and minor wall teichoic acids prevent the sidewall localization of vegetative DL-endopeptidase LytF in Bacillus subtilis. Mol Microbiol 70:297–310PubMedCrossRef

Sugai M, Fujiwara T, Komatsuzawa H, Suginaka H (1998) Identification and molecular characterization of a gene homologous to epr (endopeptidase resistance gene) in Staphylococcus aureus. Gene 224:67–75PubMedCrossRef

10.

Hashimoto M, Ooiwa S, Sekiguchi J (2012) Synthetic lethality of the lytE cwlO genotype in Bacillus subtilis is caused by lack of D,L-endopeptidase activity at the lateral cell wall. J Bacteriol 194:796–803PubMedCrossRefPubMedCentral

11.

Frankel MB, Schneewind O (2012) Determinants of murein hydrolase targeting to cross-wall of Staphylococcus aureus peptidoglycan. J Biol Chem 287:10460–10471PubMedCrossRefPubMedCentral

12.

Wise EM Jr, Park JT (1965) Penicillin: its basic site of action as an inhibitor of a peptide cross-linking reaction in cell wall mucopeptide synthesis. Proc Natl Acad Sci USA 54:75–81PubMedCrossRefPubMedCentral

13.

Denome SA, Elf PK, Henderson TA, Nelson DE, Young KD (1999) Escherichia coli mutants lacking all possible combinations of eight penicillin binding proteins: viability, characteristics, and implications for peptidoglycan synthesis. J Bacteriol 181:3981–3993PubMedPubMedCentral

14.

Imamura T, Potempa J, Tanase S, Travis J (1997) Activation of blood coagulation factor X by arginine-specific cysteine proteinases (gingipain-Rs) from Porphyromonas gingivalis. J Biol Chem 272:16062–16067PubMedCrossRef

15.

Imamura T, Tanase S, Hamamoto T, Potempa J, Travis J (2001) Activation of blood coagulation factor IX by gingipains R, arginine-specific cysteine proteinases from Porphyromonas gingivalis. Biochem J 353:325–331PubMedCrossRefPubMedCentral

16.

Komori Y, Nonogaki T, Nikai T (2001) Hemorrhagic activity and muscle damaging effect of Pseudomonas aeruginosa metalloproteinase (elastase). Toxicon 39:1327–1332PubMedCrossRef

17.

Massimi I, Park E, Rice K, Muller-Esterl W, Sauder D, McGavin MJ (2002) Identification of a novel maturation mechanism and restricted substrate specificity for the SspB cysteine protease of Staphylococcus aureus. J Biol Chem 277:41770–41777PubMedCrossRef

18.

Corrigan JJ Jr, Ray WL, May N (1968) Changes in the blood coagulation system associated with septicemia. N Engl J Med 279:851–856PubMedCrossRef

19.

Potempa J, Banbula A, Travis J (2000) Role of bacterial proteinases in matrix destruction and modulation of host responses. Periodontol 2000 24:153–192PubMedCrossRef

20.

Kessler E, Safrin M, Abrams WR, Rosenbloom J, Ohman DE (1997) Inhibitors and specificity of Pseudomonas aeruginosa LasA. J Biol Chem 272:9884–9889PubMedCrossRef

21.

Morihara K (1964) Production of elastase and proteinase by Pseudomonas aeruginosa. J Bacteriol 88:745–757PubMedPubMedCentral

22.

Potempa J, Pike RN (2009) Corruption of innate immunity by bacterial proteases. J Innate Immun 1:70–87PubMedCrossRefPubMedCentral

23.

Frick IM, Björck L, Herwald H (2007) The dual role of the contact system in bacterial infectious disease. Thromb Haemost 98:497–502PubMed

24.

Imamura T, Tanase S, Szmyd G, Kozik A, Travis J, Potempa J (2005) Induction of vascular leakage through release of bradykinin and a novel kinin by cysteine proteinases from Staphylococcus aureus. J Exp Med 201:1669–1676PubMedCrossRefPubMedCentral

25.

Sakata Y, Akaike T, Suga M, Ijiri S, Ando M, Maeda H (1996) Bradykinin generation triggered by Pseudomonas proteases facilitates invasion of the systemic circulation by Pseudomonas aeruginosa. Microbiol Immunol 40:415–423PubMedCrossRef

26.

Schmidtchen A, Frick IM, Andersson E, Tapper H, Björck L (2002) Proteinases of common pathogenic bacteria degrade and inactivate the antibacterial peptide LL-37. Mol Microbiol 46:157–168PubMedCrossRef

27.

Carlisle MD, Srikantha RN, Brogden KA (2009) Degradation of human alpha- and beta-defensins by culture supernatants of Porphyromonas gingivalis strain 381. J Innate Immun 1:118–122PubMedCrossRef

28.

Leidal KG, Munson KL, Johnson MC, Denning GM (2003) Metalloproteases from Pseudomonas aeruginosa degrade human RANTES, MCP-1, and ENA-78. J Interferon Cytokine Res 23:307–318PubMedCrossRef

29.

Matheson NR, Potempa J, Travis J (2006) Interaction of a novel form of Pseudomonas aeruginosa alkaline protease (aeruginolysin) with interleukin-6 and interleukin-8. Biol Chem 387:911–915PubMedCrossRef

30.

Baba A, Kadowaki T, Asao T, Yamamoto K (2002) Roles for Arg- and Lys-gingipains in the disruption of cytokine responses and loss of viability of human endothelial cells by Porphyromonas gingivalis infection. Biol Chem 383:1223–1230PubMedCrossRef

31.

Sheets SM, Robles-Price AG, McKenzie RM, Casiano CA, Fletcher HM (2008) Gingipain-dependent interactions with the host are important for survival of Porphyromonas gingivalis. Front Biosci 13:3215–3238PubMedCrossRefPubMedCentral

32.

Mikolajczyk-Pawlinska J, Travis J, Potempa J (1998) Modulation of interleukin-8 activity by gingipains from Porphyromonas gingivalis: implications for pathogenicity of periodontal disease. FEBS Lett 440:282–286PubMedCrossRef

33.

Kasana RC, Salwan R, Yadav SK (2011) Microbial proteases: detection, production, and genetic improvement. Crit Rev Microbiol 37:262–276PubMedCrossRef

34.

Matayoshi ED, Wang GT, Krafft GA, Erickson J (1990) Novel fluorogenic substrates for assaying retroviral proteases by resonance energy transfer. Science 247:954–958PubMedCrossRef

35.

Oliveira LC, Silva VO, Okamoto DN et al (2012) Internally quenched fluorescent peptide libraries with randomized sequences designed to detect endopeptidases. Anal Biochem 421:299–307PubMedCrossRef

36.

Ekici OD, Zhu J, Wah Chung IY, Paetzel M, Dalbey RE, Pei D (2009) Profiling the substrate specificity of viral protease VP4 by a FRET-based peptide library approach. Biochemistry 48:5753–5759PubMedCrossRef

37.

Schaal R, Kupfahl C, Buchheidt D, Neumaier M, Findeisen P (2007) Systematic identification of substrates for profiling of secreted proteases from Aspergillus species. J Microbiol Methods 71:93–100PubMedCrossRef

38.

Wildeboer D, Hill KE, Jeganathan F et al (2012) Specific protease activity indicates the degree of Pseudomonas aeruginosa infection in chronic infected wounds. Eur J Clin Microbiol Infect Dis 31:2183–9PubMedCrossRef

39.

Boyer AE, Quinn CP, Woolfitt AR et al (2007) Detection and quantification of anthrax lethal factor in serum by mass spectrometry. Anal Chem 79:8463–8470PubMedCrossRef

40.

Dunning FM, Ruge DR, Piazza TM, Stanker LH, Zeytin FN, Tucker WC (2012) Detection of botulinum neurotoxin serotype A, B, and F proteolytic activity in complex matrices with picomolar to femtomolar sensitivity. Appl Environ Microbiol 78:7687–7697PubMedCrossRefPubMedCentral

41.

Cava F, Lam H, de Pedro MA, Waldor MK (2011) Emerging knowledge of regulatory roles of D-amino acids in bacteria. Cell Mol Life Sci 68:817–831PubMedCrossRefPubMedCentral

42.

Meierhenrich UJ (2008) Amino acids and the asymmetry of life. Springer, Heidelberg, Berlin, New York

43.

Ohide H, Miyoshi Y, Maruyama R, Hamase K, Konno R (2011) D-Amino acid metabolism in mammals: biosynthesis, degradation and analytical aspects of the metabolic study. J Chromatogr B Analyt Technol Biomed Life Sci 879:3162–3168PubMedCrossRef

44.

Kaman WE, Voskamp-Visser I, de Jongh DM et al (2013) Evaluation of a D-amino-acid-containing fluorescence resonance energy transfer peptide library for profiling prokaryotic proteases. Anal Biochem 441:38–43PubMedCrossRef

45.

Galassi F, Kaman WE, Anssari Moin D et al (2012) Comparing culture, real-time PCR and fluorescence resonance energy transfer technology for detection of Porphyromonas gingivalis in patients with or without peri-implant infections. J Periodontal Res 47:616–625PubMedCrossRef

46.

Kaman WE, Galassi F, de Soet JJ et al (2012) Highly specific protease-based approach for detection of Porphyromonas gingivalis in diagnosis of periodontitis. J Clin Microbiol 50:104–112PubMedCrossRefPubMedCentral

47.

Matthews SJ, Lancaster JW (2012) Telaprevir: a hepatitis C NS3/4A protease inhibitor. Clin Ther 34:1857–1882PubMedCrossRef

48.

Brower ET, Bacha UM, Kawasaki Y, Freire E (2008) Inhibition of HIV-2 protease by HIV-1 protease inhibitors in clinical use. Chem Biol Drug Des 71:298–305PubMedCrossRef

49.

Contreras-Martel C, Amoroso A, Woon EC et al (2011) Structure-guided design of cell wall biosynthesis inhibitors that overcome beta-lactam resistance in Staphylococcus aureus (MRSA). ACS Chem Biol 6:943–951PubMedCrossRef

50.

Lee M, Hesek D, Suvorov M, Lee W, Vakulenko S, Mobashery S (2003) A mechanism-based inhibitor targeting the DD-transpeptidase activity of bacterial penicillin-binding proteins. J Am Chem Soc 125:16322–16326PubMedCrossRef

51.

Turk S, Verlaine O, Gerards T et al (2011) New noncovalent inhibitors of penicillin-binding proteins from penicillin-resistant bacteria. PLoS One 6:e19418PubMedCrossRefPubMedCentral

52.

Zervosen A, Sauvage E, Frère JM, Charlier P, Luxen A (2012) Development of new drugs for an old target: the penicillin binding proteins. Molecules 17:12478–12505PubMedCrossRef

53.

Singh SK, SaiSree L, Amrutha RN, Reddy M (2012) Three redundant murein endopeptidases catalyse an essential cleavage step in peptidoglycan synthesis of Escherichia coli K12. Mol Microbiol 86:1036–1051PubMedCrossRef

54.

Björck L, Akesson P, Bohus M et al (1989) Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor. Nature 337:385–386PubMedCrossRef

55.

Bannwarth L, Goldberg AB, Chen C, Turk BE (2012) Identification of exosite-targeting inhibitors of anthrax lethal factor by high-throughput screening. Chem Biol 19:875–882PubMedCrossRefPubMedCentral

56.

Park HC, Sung SR, Lim SM, Lee JS, Kim SK, Yoon MY (2012) Proteolytic assay-based screening identifies a potent inhibitor of anthrax lethal factor. Microb Pathog 53:109–112PubMedCrossRef

57.

Turk BE (2008) Discovery and development of anthrax lethal factor metalloproteinase inhibitors. Curr Pharm Biotechnol 9:24–33PubMedCrossRef

58.

Newman ZL, Sirianni N, Mawhinney C et al (2011) Auranofin protects against anthrax lethal toxin-induced activation of the Nlrp1b inflammasome. Antimicrob Agents Chemother 55:1028–1035PubMedCrossRefPubMedCentral

59.

Cathcart GR, Gilmore BF, Greer B, Harriott P, Walker B (2009) Inhibitor profiling of the Pseudomonas aeruginosa virulence factor LasB using N-alpha mercaptoamide template-based inhibitors. Bioorg Med Chem Lett 19:6230–6232PubMedCrossRef

60.

Cathcart GR, Quinn D, Greer B et al (2011) Novel inhibitors of the Pseudomonas aeruginosa virulence factor LasB: a potential therapeutic approach for the attenuation of virulence mechanisms in pseudomonal infection. Antimicrob Agents Chemother 55:2670–2678PubMedCrossRefPubMedCentral

61.

Kadowaki T, Yamamoto K (2003) Suppression of virulence of Porphyromonas gingivalis by potent inhibitors specific for gingipains. Curr Protein Pept Sci 4:451–458PubMedCrossRef

62.

Bodet C, Piché M, Chandad F, Grenier D (2006) Inhibition of periodontopathogen-derived proteolytic enzymes by a high-molecular-weight fraction isolated from cranberry. J Antimicrob Chemother 57:685–690PubMedCrossRef

63.

Matsushita K, Imamura T, Tomikawa M, Tancharoen S, Tatsuyama S, Maruyama I (2006) DX-9065a inhibits proinflammatory events induced by gingipains and factor Xa. J Periodontal Res 41:148–156PubMedCrossRef

64.

Matsushita K, Imamura T, Tancharoen S et al (2006) Selective inhibition of Porphyromonas gingivalis growth by a factor Xa inhibitor, DX-9065a. J Periodontal Res 41:171–176PubMedCrossRef

Titel: Bacterial proteases: targets for diagnostics and therapy
verfasst von: W. E. Kaman
J. P. Hays
H. P. Endtz
F. J. Bikker
Publikationsdatum: 01.07.2014
Verlag: Springer Berlin Heidelberg
Erschienen in: European Journal of Clinical Microbiology & Infectious Diseases / Ausgabe 7/2014
Print ISSN: 0934-9723
Elektronische ISSN: 1435-4373
DOI: https://doi.org/10.1007/s10096-014-2075-1

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Bacterial proteases: targets for diagnostics and therapy

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Blutdrucksenkung könnte Uterusmyome verhindern

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Innere Medizin

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2014

Molecular investigation of bacterial communities on intravascular catheters: no longer just Staphylococcus

Dynamic evolution and immunoreactivity of aptamers binding to polyclonal antibodies against MPT64 antigen of Mycobacterium tuberculosis

Time trends of viral meningitis among young adults in Israel: 1978–2012

A new procalcitonin cord-based algorithm in early-onset neonatal infection: for a change of paradigm

Cycloserine as an alternative urinary tract infection therapy: susceptibilities of 500 urinary pathogens to standard and alternative therapy antimicrobials

Dissemination of IMP-6-producing Pseudomonas aeruginosa ST244 in multiple cities in China

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Blutdrucksenkung könnte Uterusmyome verhindern

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

Update Innere Medizin